Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
1995-06-05
2001-11-27
Naff, David M. (Department: 1651)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S384000, C435S404000, C435S405000, C435S410000, C435S420000, C435S430100, C435S245000
Reexamination Certificate
active
06323025
ABSTRACT:
BACKGROUND OF THE INVENTION
I. Field of the Invention
The invention provides a novel group of compounds for modulating cellular activities comprising sulfur-containing hydrocarbon derivatives of carboxy-amino-amides such as vitaletheine, [N-(2-mercapto-ethane)-3-carboxyamino-propanamide], also designated[N-[3-(2-mercapto-ethanamino)-3-oxo-3,1-propanediyl]-carbamic acid], herein referred to as “vitaletheine modulators”. The compounds of the invention are characterized by a pronounced biological activity, and are useful, inter alia, for improving the phenotypic expression and vitality of cells in culture. In particular, the compounds of the invention increase cellular lifespan, increase cellular bioproductivity, improve cellular function in culture, and adapt resistant cells to culture.
“Phenotypic cell expression” is defined herein as the manifestation of an entire range of physical, biochemical and physiological characteristics of an individual cell as determined both genetically and environmentally, in contrast to “genotypic cell expression”, which in the art solely refers to the expression of the cell chromosomal sequence. [See, for example,
Dorland's Illustrated Medical Dictionary,
26th Edition, 1974, W. B. Saunders, Philadelphia]. Biological activity of the vitaletheine modulators of the invention thus includes modulation of the expression of genetic material of cells in culture as influenced by the condition and environment of each cell, including the age of the cell; the culture conditions employed, and the presence of optionally added biological effectors.
2. Discussion of Related Art
Cells which are not capable of continuous growth in culture (non-immortal cells or cell lines) are characterized by a predictable lifespan in vitro, broadly divisible into three phases corresponding to growth, maturation, and decline (i.e., senescence). Cellular senescence is a phenomenon well-recognized in the art, typically characterized, inter alia, by a statistically significant lengthening of the time required for a mature individual cell to reproduce (generation time), by the elongation of normal cell growth patterns reflecting the increasing inability of the cell to efficiently incorporate essential energy and material requirements, and by the termination or statistically significant diminution of the cell's bioproductivity, which is usually optimal at midcycle (maturity). The life spans of many non-immortal cells in culture, particularly mammalian cells, frequently varies from only a matter of hours to only several weeks, even under optimal culture conditions. Sudden, premature death of such cultures is not uncommon. Even so-called immortal cells, such as immortal insect cell lines or mammalian tumor cell lines, tend to lose viability as a function of time in culture, with corresponding decline of the cell mass. Further, many cells, such as mammalian hepatic cells, cannot be presently adapted to long-term culture as a practical matter.
These inherent limitations on cell longevity in vitro have important implications for cultures employed in chemical, industrial, and research applications, and are of particular interest in the in vitro production of mammalian cell products, including recombinant cell products, especially peptides, proteins, and glycoproteins, such as hormones, enzymes, and immunoglobulins, wherein optimum production is typically obtained during the pre-senescent phases of the cell's life-cycle. A variety of methods have been proposed for maximizing the production and longevity of cells within existing limitations imposed by cell growth patterns; these are primarily directed to the improvement of culture conditions by techniques for the rapid replenishment of nutrients and removal of wastes, such as perfusion and continuous culture procedures, or to biological manipulation of cells, such as hybridization with immortalizing cell lines. While such techniques have generally tended to improve bioproductivity in large-scale applications, the improved results are not usually attributable to alteration of cell growth patterns. Further, such prior art methods for improving cell bioproductivities have not been broadly applicable to cells considered non-adaptable to culture; the hepatic cells mentioned above, for example, are currently not maintainable in vitro under known culture conditions for more than a few hours.
Methods for the biochemical modification of cell growth patterns have also been proposed to improve cell propagation, but most have been predicated on the use of cell growth factors. While growth factors as a group generally tend to increase proliferation of cells in culture, cells exposed to these factors also rapidly become exhausted and die, with little or no net gain in cell bioproductivity. Additionally, such growth factors have not been useful in adapting resistant cells to culture.
It is accordingly desirable to provide compounds which are effective for promoting the viability and propagation of cells in culture, particularly for promoting cell vitality, cell bioproductivity, cell function, and cell longevity, and for adapting resistant cells to culture. Such compounds are potentially useful not only by themselves, but also in combination with other bioeffectors which are known to promote cellular propagation, for their contemplated combined effects, such as stabilization and augmentation of the cell biomass.
REFERENCES:
patent: 2722551 (1955-11-01), Snell
patent: 4060551 (1977-11-01), Uchikuga et al.
patent: 4102948 (1978-07-01), Feuer et al.
patent: 4218404 (1980-08-01), Feuer et al.
patent: 4552765 (1985-11-01), Mita et al.
patent: 4571430 (1986-02-01), Byrne
patent: 5370868 (1994-12-01), Knight et al.
patent: 6096536 (2000-08-01), Knight et al.
patent: 2123815 (1984-02-01), None
patent: 508792 (1978-11-01), None
Weisman et al, “Tricyclic Orthoacetamides and Orthopropionamides: Conformational Analysis and Sterochemical Effects upon13C NMR Spectra”, Tetrahdron Letters 22(44):4365-4368 (1981).
Sokolvsky et al, “On the Synthesis of Cystein Peptides”, J. Am. Chem. Soc. 86:1202-1206 (1967).
Fifth Report by T. Pantev, “Synthesis of S-(omega-Carboxamidinoalkyl-)-Isothiocarbamides”, Nauchnoizski. Inst. Radiobiol. Radiats. Knigy. 5: 57-62 (1975).
Merck Index, #221 (1974).
Garfinkel, “Is Aging Inevitable? The Intracellular Zinc Deficiency Hypothesis of Aging”, Med-Hypothesis 19(2):117-37 (1986).
Meister & Anderson, Glutathione, pp. 743-760 (1993).
Chen et al, “The Role of Cholesterol in Malignancy”, Prog. exp. Tumor Res. 22:275-316 (1978).
Gilbert, “Molecular and Cellular Aspects of Thiol-Disulfide Exchange”, Adv. Enzymol. Metab. Rel. Area 63:69-172 (1990).
Ziegler, “Role of Reversible Oxidation-Reduction of Enzyme Thiols-Disulfides in Metabolic Regulation”, Ann. Biochem. 54:305-329 (1985).
Chopra, “Sulfhydryl Groups and the Monodeiodination of Thyroxine to Triiodothyronine”, Science 199:904-905 (1978).
Kawachi et al, “Solubilization and Purification of &bgr;-Hydroxy-&bgr;-methylglutaryl Coenzyme A Reductase from Rat Liver”, Biochemistry 9:1700-1705 (1970).
Dotan et al, “Thiol-Disulfide-Dependent Interconversion of Active and Latent Forms of Rat Hepatic 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase”, Biochemica et Biophysica Acta. 713:427-434 (1982).
Sabine, Chapter 1, “General Distribution and Importance of HMGCoA Reductase”, pp. 3-18 (1979).
Rodwell et al, “Regulation of Hepatic 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase”, Adv. Enzymol. 38:373-412 (1972).
De Flora et al, “Antioxidant Activity and Other Mechanisms of Thiols Involved in Chemoprevention of Mutation and Cancer”, The American Journal of Medicine 91:3C-122S (1991).
Roederer et al, “Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine”, Proc. Natl. Acad. Sci. USA 87:4884-4888 (1990).
Tsao et al, “Glutathione and glutathione S-transferases in clones of cultured rat liver epithelial cells that express varying activity of gamma-glutamyl transpeptidase”, Mol. Carcinol. 2(3):144-9 (1989)
Knight Galen D.
Scallen Terence J.
Naff David M.
University of New Mexico
LandOfFree
In vitro cell culture in media containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vitro cell culture in media containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro cell culture in media containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2599499